Evogene Reports First Quarter 2025 Financial Results
Provided By PR Newswire
Last update: May 21, 2025
Conference call and webcast: today, May 21, 2025, 9:00 am ET
Financial Highlights:
REHOVOT, Israel, May 21, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based products, today announced its financial results for the first quarter ended March 31, 2025.
Read more at prnewswire.comNASDAQ:EVGN (11/18/2025, 10:25:03 AM)
1.18
-0.02 (-1.67%)
Find more stocks in the Stock Screener
